DESITIN PHARMA A/S: Financial statements 2022
CVR: 19389006
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,469,531 and a net result of DKK 346,301 compared with DKK 353,005 the year before. That is a decrease of 8.4% compared with the year before. Equity in the 2022 report amounted to DKK 6,413,397. The solvency ratio was 92.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,469,531
- Profit/Loss
- DKK 346,301
- Equity
- DKK 6,413,397
- Total Assets
- DKK 6,955,603
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.5M | 346K | 6.4M | 2 |
| 2021 | - | 3.8M | 353K | 6.4M | 2 |
| 2020 | - | 4.2M | 430K | 6.1M | 3 |
| 2019 | - | 5.7M | 541K | 5.7M | 4 |
| 2018 | - | 6M | 1.5M | 5.1M | - |
Official annual report
Keep an eye on DESITIN PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of July 5, 2022, Philipp Andreas Bloching has joined the board of directors of DESITIN PHARMA A/S.
As of July 5, 2022, Katrin Elisabeth Thieken has joined the board of directors of DESITIN PHARMA A/S.
As of July 5, 2022, Martin Schütt has left the board of directors of DESITIN PHARMA A/S.
As of July 5, 2022, Christoph Steinschulte has left the board of directors of DESITIN PHARMA A/S.
DESITIN PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 3,788,057, and the net result was DKK 353,005.
About DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 3,230,179 and a net result of DKK 350,332 compared with DKK 288,733 the year before. Equity in the 2026 report amounted to DKK 7,394,472.